New cancer clinical trial: An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer

Published on: February 26, 2018 at 12:00PM
Condition:   Ovarian Cancer
Intervention:   Drug: Trabectedin + PLD
Sponsors:   Suriya Yessentayeva;   Johnson & Johnson
Recruiting
http://ift.tt/2CnINfz